Kura Oncology Financial Ratios Analysis

Valuation, profitability, leverage, and liquidity ratios

Scroll to see more
BreakdownFY 2024FY 2023FY 2022FY 2021FY 2020
Period EndingDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Valuation Ratios
P/S Ratio12.57
P/B Ratio1.642.692.021.843.53
Price/Tangible Book1.642.692.021.843.53
Price/FCF5.06
Price/OCF5.04
Enterprise Value Ratios
EV/Revenue4.43
EV/FCF1.78
Profitability & Returns
Return on Equity (ROE)-0.43%-0.37%-0.29%-0.23%-0.22%
Return on Assets (ROA)-0.20%-0.23%-0.18%-0.14%-0.13%
Return on Capital Employed (ROCE)-0.28%-0.40%-0.32%-0.26%-0.15%
Leverage & Solvency Ratios
Debt/Equity0.040.040.030.010.03
Debt/FCF0.12
Liquidity Ratios
Current Ratio9.4612.2618.5623.2624.49
Quick Ratio9.3212.0518.2423.1324.34
Efficiency Ratios
Asset Turnover0.09
Yield & Distribution Ratios
Earnings Yield-0.26%-0.14%-0.16%-0.14%-0.04%
FCF Yield0.20%-0.12%-0.13%-0.11%-0.03%
Buyback Yield-0.18%-0.09%-0.01%-0.25%-0.27%